Clinical Trial Update: Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating clofarabine plus cytarabine in previously untreated acute myeloid leukemia and high-risk myelodysplastic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Clofarabine plus cytarabine (clofarabine; cytarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Myeloid, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED